Neuroscience Program

31/08/2020

ADmit Therapeutics receives 3.3 million euros from the European Commission to bring its early diagnosis test for Alzheimer’s to the market

24/08/2020

Sleep eight hours benefit the retention of weaker memories

15/07/2020

Designed a new and user-friendly model to predict the life expectancy of a severe neurodegenerative disease

23/06/2020

IDIBELL involves citizens with the survey «Health in times of confinement due to coronavirus»

04/06/2020

Discovery of a new mechanism of homeostatic plasticity in autaptic neural connections

20/05/2020

Cells of the intestine nervous system and oligodendrocytes are affected in Parkinson’s disease

08/05/2020

ADmit Therapeutics obtains the support of the Alzheimer’s Drug Discovery Foundation (ADDF) to develop its early Alzheimer’s diagnostic test.

04/05/2020

Nandu Jubany launches solidarity masks for research against the coronavirus

28/04/2020

A new platform for the diagnosis of autoimmune encephalitis receives funding from the ERC Proof of Concept grants

22/04/2020

“The research will bring us the knowledge to be able to attack the pandemic” Sebastià Videla

Scroll to Top